Tobramycin
Back to searchMolecule Structure
Scientific Name
Tobramycin
Description of the Drug
Tobramycin is an aminoglycoside antibiotic used to treat cystic fibrosis-associated bacterial, lower respiratory tract, urinary tract, eye, skin, bone, and skin structure infections.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00684
http://www.drugbank.ca/drugs/DB00684
Brand Name(s)
Aktob, Bethkis, Bramitob, Kitabis pak, Nebcin, Nebicin, Nebramycin, Nebris, Obramycin, Tobi, Tobi podhaler, Tobradex, Tobradex St, Tobralex, Tobramycin, Tobravisc, Tobrex, Tymbrineb, Vantobra
Company Owner(s)
Igi Laboratories Inc, Alkem Laboratories Ltd, Watson Laboratories Inc, Bausch And Lomb Pharmaceuticals Inc, Luoxin Aurovitas Pharma Chengdu Co Ltd, Dr Reddys Laboratories Sa, Xellia Pharmaceuticals Aps, Xgen Pharmaceuticals Djb Inc, Amneal Eu Ltd, Novartis Pharmaceuticals Corp
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| 70S ribosome | PROTEIN NUCLEIC-ACID COMPLEX | INHIBITOR | CHEMBL2364022 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL2838 | ||||
| PharmGKB | PA451704 | ||||
| Human Metabolome Database | HMDB0014822 | ||||
| DrugBank | DB00684 | ||||
| PubChem: Thomson Pharma | 14760717 | 14931869 | |||
| PubChem | 36294 | ||||
| NMRShiftDB | 60027632 | ||||
| LINCS | LSM-6534 | ||||
| Nikkaji | J4.533K | ||||
| PDBe | TOY | ||||
| BindingDB | 50366778 | ||||
| EPA CompTox Dashboard | DTXSID8023680 | ||||
| DrugCentral | 2684 | ||||
| Metabolights | MTBLC28864 | ||||
| Brenda | 107369 | 51945 | 94477 | 939 | 107368 |
| ChemicalBook | CB7154445 | ||||
| Guide to Pharmacology | 10930 | ||||
| rxnorm | TOBRAMYCIN SULFATE | TOBI | TOBRAMYCIN | TOBREX | BETHKIS |
| KEGG Ligand | C00397 | ||||
| ChEBI | 28864 | ||||
| ZINC | ZINC000008214692 |
